December 20, 2021
Recent Advance Articles
The U.S. FDA approves upadacitinib for the treatment of adults with active psoriatic arthritis.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.